cjc 1295 ipamorelin in the morning CJC-1295 No DAC & CJC-1295 + Ipamorelin: Timeline &

It is not approved for cosmetic fat loss, bodybuilding, or anti-aging, and its trials were not conducted in those populations

Advanced Recomp Stack vs common alternatives Feature Components Advanced Recomp Stack Retatrutide + CJC-1295 (No DAC) + Ipamorelin CagriSema Cagrilintide + Semaglutide Retatrutide Solo Retatrutide only Reta + MOTS-c Retatrutide + MOTS-c Feature Receptor targets Advanced Recomp Stack GLP-1 + GIP + Glucagon + GHRH + Ghrelin CagriSema GLP-1 + Amylin Retatrutide Solo GLP-1 + GIP + Glucagon Reta + MOTS-c GLP-1 + GIP + Glucagon + mitochondrial Feature GH-axis support Advanced Recomp Stack Yes CagriSema No Retatrutide Solo No Reta + MOTS-c No Feature Peak weight loss Advanced Recomp Stack ~29% from retatrutide + theoretical lean preservation CagriSema ~22-24% Phase 3 Retatrutide Solo ~29% Phase 3 Reta + MOTS-c ~29% from reta

The mean change from baseline after 1 year of treatment was + 0.9 (SD = 0.8)

It has been noted by previous research that agents that, unlike GHRH, which interacts with the GHRH receptors, molecules that interact with the ghrelin receptors may have low specificity and support multiple streams of pituitary hormone

Ipamorelin stimulates short, controlled growth hormone pulses through ghrelin receptor activation